Real-time enrollment status for this advanced endometrial carcinoma clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:02 PM UTC
| NCT Number | NCT07198074 |
| Recruiting Status | Recruiting |
| Condition | Advanced Endometrial Carcinoma |
| Phase | PHASE3 |
| Target Enrollment | 255 participants |
| Active Locations | 303 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | October 9, 2026 (3 days ago) |
As of October 12, 2026: Clinical trial NCT07198074 is currently recruiting participants. This phase3 study for advanced endometrial carcinoma is actively seeking new participants at 303 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07198074 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 303 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07198074 was last updated 3 days ago (October 9, 2026). HelloStudys verifies this status automatically.